Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alpha Tau Medical Ltd. - Ordinary Shares
(NQ:
DRTS
)
8.110
+0.080 (+1.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
247,999
Open
8.000
Bid (Size)
8.050 (300)
Ask (Size)
8.270 (3,300)
Prev. Close
8.030
Today's Range
7.900 - 8.300
52wk Range
2.500 - 8.600
Shares Outstanding
68,575,397
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference
March 16, 2026
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
February 24, 2026
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Performance
YTD
+67.9%
+67.9%
1 Month
+14.7%
+14.7%
3 Month
+25.5%
+25.5%
6 Month
+102.7%
+102.7%
1 Year
+207.2%
+207.2%
More News
Read More
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
January 06, 2026
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
January 05, 2026
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
In today's session, these stocks are experiencing unusual volume.
↗
December 11, 2025
Via
Chartmill
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
December 09, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 04, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
December 02, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 22, 2025
Via
Benzinga
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
October 21, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
September 02, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish
↗
May 20, 2025
Via
Stocktwits
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 28, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
April 02, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
March 18, 2025
Via
ACCESS Newswire
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
February 24, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
February 03, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
January 27, 2025
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
December 18, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
December 17, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
October 21, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Treats First Patient with Recurrent Lung Cancer
October 10, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
↗
August 14, 2024
Via
InvestorPlace
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
June 25, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Frequently Asked Questions
Is Alpha Tau Medical Ltd. - Ordinary Shares publicly traded?
Yes, Alpha Tau Medical Ltd. - Ordinary Shares is publicly traded.
What exchange does Alpha Tau Medical Ltd. - Ordinary Shares trade on?
Alpha Tau Medical Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alpha Tau Medical Ltd. - Ordinary Shares?
The ticker symbol for Alpha Tau Medical Ltd. - Ordinary Shares is DRTS on the Nasdaq Stock Market
What is the current price of Alpha Tau Medical Ltd. - Ordinary Shares?
The current price of Alpha Tau Medical Ltd. - Ordinary Shares is 8.110
When was Alpha Tau Medical Ltd. - Ordinary Shares last traded?
The last trade of Alpha Tau Medical Ltd. - Ordinary Shares was at 04/20/26 04:00 PM ET
What is the market capitalization of Alpha Tau Medical Ltd. - Ordinary Shares?
The market capitalization of Alpha Tau Medical Ltd. - Ordinary Shares is 556.15M
How many shares of Alpha Tau Medical Ltd. - Ordinary Shares are outstanding?
Alpha Tau Medical Ltd. - Ordinary Shares has 556M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
